All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease.
Expert Rev Neurother
; 9(11): 1615-21, 2009 Nov.
Article
en En
| MEDLINE
| ID: mdl-19903021
Retinoic acid, an essential factor derived from vitamin A, has been shown to have a variety of functions including roles as an antioxidant and in cellular differentiation. Since oxidative stress and dedifferentiation of neurons appear to be common pathological elements of a number of neurodegenerative disorders, we speculated that retinoic acid may offer therapeutic promise. In this vein, recent compelling evidence indicates a role of retinoic acid in cognitive activities and anti-amyloidogenic properties. Here, we review the actions of retinoic acid that indicate that it may have therapeutic properties ideally served for the treatment of neurodegenerative diseases such as Alzheimer's disease.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Tretinoina
/
Encéfalo
/
Fármacos Neuroprotectores
/
Enfermedad de Alzheimer
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Expert Rev Neurother
Asunto de la revista:
NEUROLOGIA
/
TERAPEUTICA
Año:
2009
Tipo del documento:
Article
País de afiliación:
Estados Unidos